Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-13 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
S | Common Stock | D | 5000 | $65.57 - $65.57 | $327,843 |
| 2024-11-13 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
M | Common Stock | A | 5000 | $45.28 - $45.28 | $226,383 |
| 2024-11-05 | Edwards Lifesciences Corp | Wood Larry L
(Global President TAVR & Surg) |
S | Common Stock | D | 25000 | $65.91 - $65.91 | $1,647,862 |
| 2024-10-15 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
S | Common Stock | D | 5000 | $69.51 - $69.51 | $347,533 |
| 2024-10-15 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
M | Common Stock | A | 5000 | $45.28 - $45.28 | $226,383 |
| 2024-09-14 | Edwards Lifesciences Corp | Markowitz Wayne
(GM & SVP, Surgical) |
F | Common Stock | D | 648 | $68.52 - $68.52 | $44,400 |
| 2024-09-13 | Edwards Lifesciences Corp | Dahl Andrew M.
(SVP, Corporate Controller) |
A | Common Stock | A | 2920 | $0.00 - $0.00 | $0 |
| 2024-09-11 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
S | Common Stock | D | 5000 | $66.77 - $66.77 | $333,825 |
| 2024-09-11 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
M | Common Stock | A | 5000 | $45.28 - $45.28 | $226,383 |
| 2024-08-20 | Edwards Lifesciences Corp | Chopra Daveen
(CVP, TMTT) |
S | Common Stock | D | 1250 | $69.95 - $69.95 | $87,437 |
| 2024-08-14 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
S | Common Stock | D | 5000 | $66.08 - $66.08 | $330,420 |
| 2024-08-14 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
M | Common Stock | A | 5000 | $45.28 - $45.28 | $226,383 |
| 2024-07-11 | Edwards Lifesciences Corp | Lippis Daniel J.
(CVP, JAPAC) |
S | Common Stock | D | 500 | $94.18 - $94.18 | $47,090 |
| 2024-07-11 | Edwards Lifesciences Corp | Lippis Daniel J.
(CVP, JAPAC) |
M | Common Stock | A | 500 | $45.28 - $45.28 | $22,638 |
| 2024-07-10 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
S | Common Stock | D | 5000 | $93.29 - $93.29 | $466,474 |
| 2024-07-10 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
M | Common Stock | A | 5000 | $45.28 - $45.28 | $226,383 |
| 2024-07-10 | Edwards Lifesciences Corp | Feinberg David T
(Director) |
A | Common Stock | A | 2308 | $0.00 - $0.00 | $0 |
| 2024-07-07 | Edwards Lifesciences Corp | Szyman Catherine M.
(CVP, Critical Care) |
F | Common Stock | D | 258 | $92.32 - $92.32 | $23,818 |
| 2024-07-07 | Edwards Lifesciences Corp | Lippis Daniel J.
(CVP, JAPAC) |
F | Common Stock | D | 410 | $92.32 - $92.32 | $37,851 |
| 2024-07-07 | Edwards Lifesciences Corp | Lemercier Jean-Luc M
(CVP, EMEACLA and JAPAC) |
F | Common Stock | D | 82 | $92.32 - $92.32 | $7,570 |
| 2024-06-20 | Edwards Lifesciences Corp | Lippis Daniel J.
(CVP, JAPAC) |
S | Common Stock | D | 535 | $90.00 - $90.00 | $48,150 |
| 2024-06-20 | Edwards Lifesciences Corp | Lippis Daniel J.
(CVP, JAPAC) |
M | Common Stock | A | 535 | $45.28 - $45.28 | $24,223 |
| 2024-06-20 | Edwards Lifesciences Corp | Ullem Scott B.
(CVP, Chief Financial Officer) |
S | Common Stock | D | 5625 | $87.47 - $88.11 | $492,257 |
| 2024-06-20 | Edwards Lifesciences Corp | Ullem Scott B.
(CVP, Chief Financial Officer) |
M | Common Stock | A | 5625 | $45.28 - $45.28 | $254,681 |
| 2024-06-12 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
S | Common Stock | D | 5000 | $87.54 - $87.54 | $437,696 |
| 2024-06-12 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
M | Common Stock | A | 5000 | $45.28 - $45.28 | $226,383 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |